(Q35738820)

English

Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: the tumor selectivity of the treatment as a function of tumor to liver flow ratio

scientific article published on 14 March 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 August 2017

Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: the tumor selectivity of the treatment as a function of tumor to liver flow ratio (English)

1 reference

Europe PubMed Central

10 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Seza A Gulec

1

1 reference

Europe PubMed Central

10 August 2017

Geraldine Mesoloras

2

1 reference

Europe PubMed Central

10 August 2017

William A Dezarn

3

1 reference

Europe PubMed Central

10 August 2017

Patrick McNeillie

4

1 reference

Europe PubMed Central

10 August 2017

Andrew S Kennedy

5

1 reference

Europe PubMed Central

10 August 2017

publication date

14 March 2007

1 reference

Europe PubMed Central

10 August 2017

Journal of Translational Medicine

1 reference

Europe PubMed Central

10 August 2017

5

1 reference

Europe PubMed Central

10 August 2017

15

1 reference

Europe PubMed Central

10 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

14 March 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

https://scigraph.springernature.com/pub.10.1186/1479-5876-5-15

0 references

Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1845138

12 July 2018

Relationship of 99mtechnetium labelled macroaggregated albumin (99mTc-MAA) uptake by colorectal liver metastases to response following Selective Internal Radiation Therapy (SIRT)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1845138

12 July 2018

Angiographic considerations in patients undergoing liver-directed therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1845138

12 July 2018

Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1845138

12 July 2018

Yttrium-90 microspheres: radiation therapy for unresectable liver cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1845138

12 July 2018

Tumour-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1845138

12 July 2018

Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1845138

12 July 2018

Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheres

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1845138

12 July 2018

Tolerance of the liver to the effects of Yttrium-90 radiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1845138

12 July 2018

Dose distribution following selective internal radiation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1845138

12 July 2018

Internal hepatic radiotherapy: II. Intra-arterial radiocolloid therapy for hepatic tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1845138

12 July 2018

Dosimetric techniques in 90Y-microsphere therapy of liver cancer: The MIRD equations for dose calculations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1845138

25 September 2018

Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1845138

25 September 2018

Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1845138

25 September 2018

Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1845138

25 September 2018

Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1845138

25 September 2018

Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1845138

25 September 2018

Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1845138

25 September 2018

Selective internal radiation therapy (SIRT) with 90Yttrium microspheres for extensive colorectal liver metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1845138

25 September 2018

Tumour dosimetry in human liver following hepatic yttrium-90 microsphere therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17359531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic pharmaco-scintigraphy with hepatic intra-arterial technetium-99m macroaggregated albumin in the determination of tumour to non-tumour uptake ratio in hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17359531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RADIOACTIVE ISOTOPES FOR ADJUVANT CANCER THERAPY; ANIMAL EXPERIMENTATION AND PRELIMINARY RESULTS IN HUMAN APPLICATION

1 reference

https://pubmed.ncbi.nlm.nih.gov/17359531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17359531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RADIATION HEPATITIS

1 reference

https://pubmed.ncbi.nlm.nih.gov/17359531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization

1 reference

https://pubmed.ncbi.nlm.nih.gov/17359531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of symptomatic metastatic cancer to the liver from primary colon and rectal cancer by the intraarterial administration of chemotherapy and radioactive isotopes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17359531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathogenesis of veno-occlusive liver disease after radiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17359531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of liver metastases following treatment with yttrium-90 microspheres

1 reference

https://pubmed.ncbi.nlm.nih.gov/17359531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of asymptomatic metastatic cancer to the liver from primary colon and rectal cancer by the intraarterial administration of chemotherapy and radioactive isotopes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17359531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres

1 reference

https://pubmed.ncbi.nlm.nih.gov/17359531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1479-5876-5-15

1 reference

Europe PubMed Central

10 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35738820&oldid=1802999172"